reference/36468969

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36468969

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	114
issn	1522-8517 1523-5866
issueIdentifier	1
pageRange	100-114
publicationName	Neuro-Oncology
startingPage	100
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_34c6c85f43c7ddd0e9ddd0b8a0e0bcaf http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_977cd13b9ed780b8d82f5c6c8f959562 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_acf315174b091ea5a05dc27019771617 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_89e9a269f9c687a3fb70befe4e8ac03b
bibliographicCitation	Hong B, Yang E, Su D, Ju J, Cui X, Wang Q, Tong F, Zhao J, Yang S, Cheng C, Xin L, Xiao M, Yi K, Zhan Q, Ding Y, Xu H, Cui L, Kang C. EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma. Neuro Oncol. 2024 Jan 05;26(1):100–14. PMID: 37651725; PMCID: PMC10768988.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4040a5994d59dde7ff5d67f5839b6436 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_170fcb9957449f8ecd050b6654c67cff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_731d69d482cde276afb655e8af51e9b2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b44a64eb8c7da1444e962c47c3e5ca33 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_035a98d3cbd21cdf81788785df017d8a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4884b83025e5d73d61b54fba625c9d14 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_141dd08b09b940d579cc2d06a81dd7bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a562e286e0c49a44901efa96c46c941 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd89b27ba3398e531f9c4191ae5f8951 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e21dd6d563786021991ab7c0c813b1d8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_653f92316d87c2412935caf25bf37004 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8fb9a6d064dc014b6565491d45814f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9563d225d5ddd8da0c2bf98aade7f9f4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3255-3369 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d5ffd42bd8d8c4e72dba9e73fb25551a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4699684d2a9b6118015f8e954f2ee3f3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed90a56c0328e0ccdd18d69521cdfff8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d5a2802a33159a4aae06aa2409f19e8
date	2023-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/37651725 https://doi.org/10.1093/neuonc/noad159 https://pubmed.ncbi.nlm.nih.gov/PMC10768988
isPartOf	https://portal.issn.org/resource/ISSN/1523-5866 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21645 https://portal.issn.org/resource/ISSN/1522-8517
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	EPIC-1042 as a potent PTRF/Cavin1–caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma
discusses	http://id.nlm.nih.gov/mesh/M0023492 http://id.nlm.nih.gov/mesh/M0005636 http://id.nlm.nih.gov/mesh/M0209023 http://id.nlm.nih.gov/mesh/M0448961 http://id.nlm.nih.gov/mesh/M0136562 http://id.nlm.nih.gov/mesh/M0028268 http://id.nlm.nih.gov/mesh/M0483208 http://id.nlm.nih.gov/mesh/M000613201

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID857 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID284119

Total number of triples: 54.